What is the recommended protocol for administering rituximab in patients with rheumatoid arthritis?
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901286916456448 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Rituximab administration in rheumatoid arthritis generally involves two 1,000 mg infusions two weeks apart, repeated at intervals of at least 16 weeks, and is often combined with methotrexate to enhance treatment efficacy. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20040206 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the recommended protocol for administering rituximab in patients with rheumatoid arthritis? Tripdatabase rituximab rheumatoid arthritis treatment protocol drug administration rheumatology pharmacology Rituximab administration in rheumatoid arthritis generally involves two 1,000 mg infusions two weeks apart, repeated at intervals of at least 16 weeks, and is often combined with methotrexate to enhance treatment efficacy. |
| title | What is the recommended protocol for administering rituximab in patients with rheumatoid arthritis? |
| topic | rituximab rheumatoid arthritis treatment protocol drug administration rheumatology pharmacology |
| url | https://doi.org/10.5281/zenodo.20040206 |